← Leaderboards
Daryl A Bosco
Univ Of Massachusetts Med Sch Worcester
$10,705,670
Attributed
$15,685,849
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,685,849 · 10
By mechanism
R01$11,172,862 · 5
RF1$3,323,710 · 1
R21$1,170,204 · 3
F32$19,073 · 1
Top collaborators
- Clotilde Lagier-Tourenne6 shared
- Francesca Massi5 shared
- Gerardo Andres Morfini1 shared
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Zuoshang Xu$14,371,059
- Francesca Massi$6,479,357
- Jonathan K Watts$5,302,344
- Eric Wayne Danielson$172,166
- Stephen Jones$8,264,263
Others in their field
Top investigators on “Amyotrophic Lateral Sclerosis”
- Merit E Cudkowicz · Massachusetts General Hospital$54,029,758
- James Dale Berry · Brigham And Women'S Hospital$37,291,450
- Sabrina Paganoni · Massachusetts General Hospital$36,168,406
- Suma Babu · Massachusetts General Hospital$36,168,406
- Jeffrey D Rothstein · Massachusetts General Hospital$22,909,620
- Teepu Siddique · University Of Chicago$22,641,778
Research focus
Amyotrophic Lateral SclerosisMutantMutationProteinsNeurodegenerative DisordersMotor NeuronsPhenotypeGenesPathogenesisLinkCellsIn VitroPlayInheritedMediatingPathway InteractionsExhibitsInduced Pluripotent Stem CellAffectProteomicsDefectTissuesComplexNeurons
Grant awards (30)
Investigating aberrant vesicular degradation and lipid metabolism in neurodegeneration$3,323,710
RF1 · FY2025 · NS · contact PI
Investigating Dysfunction of Neuroimmune-Related Processes in Models of ALS/FTD TDP-43$251,250
R21 · FY2025 · NS · contact PI
Impact of ALS-linked mutations on the structure, dynamics and function of profilin-1$521,114
R01 · FY2024 · GM
Disruption of Nucleocytoplasmic Transport in FUS-related Neurodegenerative Diseases$776,944
R01 · FY2023 · NS · contact PI
Impact of ALS-linked mutations on the structure, dynamics and function of profilin-1$521,114
R01 · FY2023 · GM
Disruption of Nucleocytoplasmic Transport in FUS-related Neurodegenerative Diseases$790,424
R01 · FY2022 · NS · contact PI
Impact of ALS-linked mutations on the structure, dynamics and function of profilin-1$521,114
R01 · FY2022 · GM
Disruption of nucleocytoplasmic transport in FUS-related neurodegenerative diseases$806,490
R01 · FY2021 · NS · contact PI
Impact of ALS-linked mutations on the structure, dynamics and function of profilin-1$507,572
R01 · FY2021 · GM
Disruption of nucleocytoplasmic transport in FUS-related neurodegenerative diseases$86,783
R01 · FY2021 · NS · contact PI
Disruption of nucleocytoplasmic transport in FUS-related neurodegenerative diseases$814,945
R01 · FY2020 · NS · contact PI
Role of p38alpha signaling in mutant SOD1-linked motor neuron disease$458,329
R21 · FY2020 · NS
Disruption of nucleocytoplasmic transport in FUS-related neurodegenerative diseases$831,820
R01 · FY2019 · NS · contact PI
Misfolded ALS-linked Profilin-1: a novel therapeutic target$364,766
R01 · FY2018 · NS · contact PI
Misfolded ALS-linked Profilin-1: a novel therapeutic target$364,766
R01 · FY2017 · NS · contact PI
Misfolded ALS-linked Profilin-1: a novel therapeutic target$364,766
R01 · FY2016 · NS · contact PI
Investigating a Toxic Gain-of-Interaction Between FUS/TLS & Stress Granules$359,844
R01 · FY2016 · NS · contact PI
Investigating the response of FUS/TLS to excitotoxic insult$209,375
R21 · FY2016 · NS · contact PI
Misfolded ALS-linked Profilin-1: a novel therapeutic target$364,766
R01 · FY2015 · NS · contact PI
Investigating a Toxic Gain-of-Interaction Between FUS/TLS & Stress Granules$359,844
R01 · FY2015 · NS · contact PI
Investigating the response of FUS/TLS to excitotoxic insult$251,250
R21 · FY2015 · NS · contact PI
Misfolded ALS-linked Profilin-1: a novel therapeutic target$379,395
R01 · FY2014 · NS · contact PI
Investigating a Toxic Gain-of-Interaction Between FUS/TLS & Stress Granules$323,859
R01 · FY2014 · NS · contact PI
Investigating a Toxic Gain-of-Interaction Between FUS/TLS & Stress Granules$347,250
R01 · FY2013 · NS · contact PI
Investigation of post-translational modifications in WT SOD1 in sporadic ALS$340,304
R01 · FY2013 · NS · contact PI
Investigating a Toxic Gain-of-Interaction Between FUS/TLS & Stress Granules$359,844
R01 · FY2012 · NS · contact PI
Investigation of post-translational modifications in WT SOD1 in sporadic ALS$352,647
R01 · FY2012 · NS · contact PI
Investigation of post-translational modifications in WT SOD1 in sporadic ALS$352,647
R01 · FY2011 · NS · contact PI
Investigation of post-translational modifications in WT SOD1 in sporadic ALS$359,844
R01 · FY2010 · NS · contact PI
Oxidative metabolites in Alpha-Synucleinopathies$19,073
F32 · FY2005 · NS